about
Defining response to anti-VEGF therapies in neovascular AMDDoes cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?Spectral domain optical coherence tomography can detect visible and subthreshold laser burns using 532-nm laser.Drusen detection in retro-mode imaging by a scanning laser ophthalmoscope.25th RCOphth Congress, President's Session paper: 25 years of progress in medical retina.Quantification of visual field loss in age-related macular degeneration.Optical coherence tomography confirmed resolution of macular edema in a diabetic patient after hemodialysis.Multispectral retinal image analysis: a novel non-invasive tool for retinal imaging.Ranibizumab 0.5 mg for Diabetic Macular Edema with Bimonthly Monitoring after a Phase of Initial Treatment: 18-Month, Multicenter, Phase IIIB RELIGHT Study.Evaluating digital diabetic retinopathy screening in people aged 90 years and over.Diagnosis of retinopathy in children younger than 12 years of age: implications for the diabetic eye screening guidelines in the UK.'I'd like to know what causes it, you know, anything I've done?' Are we meeting the information and support needs of patients with macular degeneration? A qualitative studyA case of presumed congenital herpes zoster ophthalmicus.Changes in intraocular pressure in study and fellow eyes in the IVAN trial.What do we know about the experience of age related macular degeneration? A systematic review and meta-synthesis of qualitative research.Functional and Structural Findings of Neurodegeneration in Early Stages of Diabetic Retinopathy: Cross-sectional Analyses of Baseline Data of the EUROCONDOR Project.Living together with age-related macular degeneration: An interpretative phenomenological analysis of sense-making within a dyadic relationship.Multispectral imaging of the ocular fundus using light emitting diode illumination.Photodynamic therapy: a treatment option in choroidal neovascularisation secondary to punctate inner choroidopathy.Acute annular outer retinopathy.Abnormal retinal vascular function and lipid levels in a sample of healthy UK South Asians.The efficacy and safety of intravitreal dexamethasone implants for macular oedema secondary to retinal vein occlusion: 3-year experience.How do older people with sight loss manage their general health? A qualitative study.Regression analysis of ranked segment parameters for optic nerve head classification: a pilot study.Quantitative analysis of multi-spectral fundus images.Angle closure glaucoma and diagnostic mydriasis.Cardiovascular therapies and their role in diabetic eye diseaseAge-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunctionPrevalence of age-related maculopathy at two points in time in an elderly British populationA 'fail-safe' screening programme for diabetic retinopathyCarotid artery Doppler ultrasonography in retinal macroaneurysmsNew developments in retinal drusenRetinal changes associated with tamoxifen treatment for breast cancerScreening for eye disease in the elderly: is it worth it?Spontaneously resolved macroaneurysm associated with a congenital anomalous retinal arteryDiabetes: Intravitreous ranibizumab for proliferative diabetic retinopathy
P50
Q26996510-2C0A9EDD-0696-43F9-AC85-DD974798A996Q28167359-667EB2AB-D0E0-4D93-8306-3ECA2EB61A04Q33758517-BE4822D7-919B-4EB5-80AB-D139FC7BC63EQ33824057-C1348B08-F1C0-4CB3-966D-F5BB7D0E5475Q34200374-DFE68ED1-2EF4-4971-A3E2-9392D86F6A37Q34328442-88D6A474-9972-47FB-8BC5-07D97EC30470Q35414908-B4190416-79F9-4C96-88C3-9DFCF0E56F5BQ35603511-2E8BBF17-2076-474E-92BD-B670E8218BCDQ35684850-C9A1C803-2597-4099-B3BF-6D65859ED2A8Q36750312-9C0C3C2C-9DE3-4861-A1B3-2FDE5419FF9FQ37085379-354BA97E-31FB-4EFC-B5FC-256E4D6C4B49Q37293286-A11560F2-523B-40D4-9AEC-0CDF0AF46880Q37302444-0886B8CC-B02C-4689-89AF-77DABD2AA136Q37600185-5D81914E-37DC-4482-B6D2-D91CCD4CC7B0Q38019618-F80E4D2C-3F45-4502-AB6F-9CD6752E00E7Q38701637-1D95C19C-61D1-4454-A648-C6595114541CQ39260212-22A902B3-F0B2-4EB6-88F5-0DD641857D0FQ42871844-AEFB6144-6D79-434D-B1F5-283019736431Q43008541-5E2B6D69-F31D-4FE3-B06B-E870001952CDQ44049773-000A31D0-55A4-4843-9128-24D5485ACD55Q45828456-9D68E5D7-A5E5-461D-9D5F-3416F11F45D5Q48297596-0964A8BB-40BB-4AAE-AC1A-6EE508F0B686Q50241130-2587E9DF-5204-4A9D-A57F-72D42A298A68Q51921576-55C5C027-CC6F-4FBC-ACD7-2C3583052E4EQ51936897-E6CACDE4-1D36-41A0-988A-71676E72706AQ54038570-EBD5C5EF-4103-4A02-A8E6-5A056CEE256AQ61953755-C38B09CA-D2BB-4326-AD66-0722BDD34CA8Q73738846-D20BDE52-C588-4F5A-974D-6ADECD3427F6Q73887239-3A764A1E-3A0E-479B-AA6E-12785E5926ECQ74579364-98DE093C-FBB6-4AD0-BB5B-36031D2C0B32Q74616525-C55E18A1-83A4-43F2-9F44-7B1872258FC3Q74841081-EDFAE9AE-4994-4B67-9913-03B8E40815A1Q77421543-EA335C8C-8724-4AF3-A287-4A1ADC28BA3BQ84992518-3D839EB1-9A2D-4B32-BA6B-92896605BCBAQ85948095-776D5186-D8D8-4008-ACA3-E23F8F2929DFQ87129395-51D196EA-72FE-4185-ACA8-670EE5AD6D99
P50
description
researcher ORCID ID = 0000-0002-9281-5244
@en
wetenschapper
@nl
name
Jonathan M Gibson
@ast
Jonathan M Gibson
@en
Jonathan M Gibson
@es
Jonathan M Gibson
@nl
type
label
Jonathan M Gibson
@ast
Jonathan M Gibson
@en
Jonathan M Gibson
@es
Jonathan M Gibson
@nl
prefLabel
Jonathan M Gibson
@ast
Jonathan M Gibson
@en
Jonathan M Gibson
@es
Jonathan M Gibson
@nl
P1153
P106
P108
P1153
35398710300
55455442500
56706818300
56975806100
57072394900
57195433699
P21
P31
P496
0000-0002-9281-5244